Roche Vs. Eli Lilly: Nvidia Deals, Obesity Battles Stoke Rivalry (I'd Buy Both)
Source: SeekingAlpha
2026-03-18 13:57:48 ET
Intro: Has Roche Just Eclipsed Eli Lilly In The Battle For AI Drug Development Supremacy?
Read the full article on Seeking Alpha
For further details see:
Roche Vs. Eli Lilly: Nvidia Deals, Obesity Battles Stoke Rivalry (I'd Buy Both)
Roche Holding Ltd ADR
NASDAQ: RHHBY
RHHBY Trading
-0.2% G/L:
$48.13 Last:
1,348,624 Volume:
$47.65 Open:
RHHBY Latest News
March 24, 2026 02:00:00 am
Roche launches the cobas eplex respiratory pathogen panel 3, a fast and comprehensive test to help clinicians treat patients with respiratory infections, in CE markets
RHHBY Stock Data
$361,973,933,704
6,306,832,002
N/A
43
N/A
Pharmaceuticals
Healthcare
CH
Basel Switzerland
